ENGLISH ABSTRACT
JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

[Scorpionfish (Scorpaena plumieri) envenomation in a fishing and turistic community of Paraguaná peninsula, Falcón state, Venezuela: clinical, epidemiological and treatment aspects].

Thirty six patients apparently envenomed by the scorpion fish Scorpaena plumieri, consulting to the ambulatory emergency of a fishing and turistic town Adícora, state Falcón, Venezuela, from December 2006 to April 2007, allowed us to carry out a descriptive analysis of the clinical, epidemiology and treatment of this envenoming. Envenomation percentages were not significantly different between sex or age (X2=0.03, p= 0.758; X2=0.06; p=0.81, respectively). Most of the accidents occurred in february and april (> 50%), in the afternoon (83.33%) when individuals were bathing or swimming at the beach (97.22%), suggesting a seasonal pattern. The time between ambulatory medical assistance and the accident varied from 3 to 30 minutes, with a mean time of 5.97 +/- 4.39. The cutting injuries were located at the feet in all patients, with 0.2 to 3 cm (X=1.04 +/- 0.86) of length and between 1 to 2 mm of width. Clinical manifestations observed were: intense and irradiated pain (100%) (VAS=X: 9.39 +/- 0.60), edema (27.78%) and erythema (22.22%). One case had systemic manifestations: hypotension and faintness. Treatment consisted of infiltration with lidocaine (1%), systemic anti-inflmatory-analgesia (100 mg, orally every 8 hours for 5 days) and antibiotic therapy per os (500 mg, 2 daily dose for 10 days). All patients had a satisfactory post-treatment evolution, between 5 to 120 (X=30.11 +/- 33.30) minutes, with a pain VAS mean values significantly lower (0.72 +/- 0.62; t=52.2, p=0.0001).

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app